Pfizer Inc. (PFE) Stock Analysis — Probabli.AI
AI-powered analysis for PFE (Pfizer Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
← Healthcare Stocks
Last price: $27.00 · Market cap: $155.7B · AI consensus: Bullish
Pfizer Inc. (PFE) demonstrates strong financial health with consistent earnings beat streaks and innovative drug approvals. While facing challenges with negative revenue growth and patent concerns, its high dividend yield, strategic partnerships, and robust pipeline of treatments solidify a bullish long-term outlook. Price projections reflect potential upside supported by these fundamentals.
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3000% · Bear 1500%
- Pfizer's strong earnings beat streak, consistent positive EPS surprises, and recent FDA approval for a new Alzheimer's drug indicate robust operational performance and potential upside scenarios. Although facing patent…
5-Year Outlook
- Bull 6000% · Neutral 2500% · Bear 1500%
SWOT Highlights
- Strength: Strong dividend yield of 6.37%.
- Strength: FDA approvals for key drugs like Alzheimer's treatment.
- Risk: Revenue growth forecast is negative.
- Risk: High payout ratio suggesting limited dividend sustainability.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate PFE a BUY with a mean price target of $29.21. Pfizer Inc. currently pays a dividend with a yield of approximately 6.37%.
Analysis generated Apr 26, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/PFE.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.